JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263313

Human PRAP1 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

PRAP1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.
1 Images
Sanger Sequencing - Human PRAP1 knockout HeLa cell lysate (AB263313)
  • Sanger seq

Unknown

Sanger Sequencing - Human PRAP1 knockout HeLa cell lysate (AB263313)

Homozygous : 1 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263313-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PRAP1 knockout HeLa cell lysate", "number":"AB263313-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263313-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
PRAP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PRAP1 sometimes referred to as Proline-Rich Acidic Protein 1 is a protein with a mass of approximately 18 kDa. It localizes mainly in the cell nucleus and has a restricted expression pattern found predominately in epithelial tissues such as the gastrointestinal tract and the reproductive system. This suggests that it might have functions related to those specific cell types.
Biological function summary

PRAP1 plays a role in cellular processes such as proliferation and differentiation. It does not seem to form part of any well-characterized multiprotein complex but its expression pattern implies a relevance in the development and maintenance of epithelial cells. Studies have suggested that PRAP1 may interact with various nuclear factors potentially influencing transcriptional regulation in specific tissue types.

Pathways

PRAP1's function involves processes that maintain epithelial integrity and renewal. It has associations with the Wnt signaling pathway which is important for regulating tissue homeostasis and cellular proliferation. PRAP1 may interact with proteins like β-catenin an important player in Wnt signaling although direct interactions remain experimentally undefined.

Research indicates PRAP1 could be implicated in cancer especially those originating from epithelial tissues like colorectal cancer. Alterations in PRAP1 expression and function might contribute to oncogenesis or tumor progression. Furthermore PRAP1 shows potential links to inflammatory disorders with altered activity potentially affecting proteins such as NF-κB a critical regulator in inflammatory responses.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com